INFU RSI Chart
Last 7 days
-3.2%
Last 30 days
-5.5%
Last 90 days
-16.1%
Trailing 12 Months
0.3%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 113.5M | 118.2M | 122.8M | 0 |
2022 | 104.7M | 106.9M | 107.6M | 109.9M |
2021 | 100.3M | 99.1M | 100.6M | 102.4M |
2020 | 84.5M | 90.8M | 94.4M | 97.4M |
2019 | 68.8M | 72.2M | 77.0M | 81.1M |
2018 | 69.9M | 69.4M | 68.5M | 67.1M |
2017 | 69.9M | 68.7M | 69.0M | 71.1M |
2016 | 72.3M | 73.5M | 72.4M | 70.5M |
2015 | 65.8M | 66.4M | 68.1M | 70.5M |
2014 | 64.8M | 66.5M | 67.4M | 66.5M |
2013 | 59.2M | 59.8M | 61.3M | 62.3M |
2012 | 56.0M | 57.0M | 56.6M | 58.8M |
2011 | 49.3M | 51.9M | 53.7M | 54.6M |
2010 | 0 | 41.7M | 44.5M | 47.2M |
2009 | 0 | 0 | 0 | 39.0M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 01, 2024 | lachance carrie | acquired | - | - | 50,000 | president and coo |
Mar 01, 2024 | lachance carrie | sold (taxes) | -186,298 | 9.3 | -20,032 | president and coo |
Feb 09, 2024 | chupa addam | sold (taxes) | -13,190 | 9.6 | -1,374 | executive vp and cio |
Feb 09, 2024 | chupa addam | acquired | - | - | 3,000 | executive vp and cio |
Sep 06, 2023 | malhotra r. rimmy | sold | -126,072 | 10.0858 | -12,500 | - |
Sep 05, 2023 | malhotra r. rimmy | sold | -50,972 | 10.1945 | -5,000 | - |
Sep 01, 2023 | malhotra r. rimmy | sold | -128,036 | 10.2429 | -12,500 | - |
Aug 31, 2023 | malhotra r. rimmy | sold | -103,643 | 10.3643 | -10,000 | - |
Aug 30, 2023 | malhotra r. rimmy | sold | -50,871 | 10.1742 | -5,000 | - |
Aug 29, 2023 | malhotra r. rimmy | sold | -103,357 | 10.3357 | -10,000 | - |
Which funds bought or sold INFU recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 11, 2024 | VANGUARD GROUP INC | added | 2.3 | 1,189,900 | 11,228,200 | -% |
Mar 05, 2024 | GREENWOOD CAPITAL ASSOCIATES LLC | added | 93.85 | 1,060,020 | 2,006,860 | 0.13% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | reduced | -0.4 | 7,779 | 95,166 | -% |
Feb 15, 2024 | Legal & General Group Plc | reduced | -9.13 | -135 | 20,658 | -% |
Feb 15, 2024 | BARCLAYS PLC | added | 552 | 232,000 | 270,000 | -% |
Feb 15, 2024 | Meros Investment Management, LP | added | 0.42 | 831,436 | 9,318,310 | 4.42% |
Feb 15, 2024 | PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | reduced | -0.49 | 796,946 | 9,857,760 | 0.58% |
Feb 14, 2024 | WASATCH ADVISORS LP | added | 3.41 | 1,030,720 | 8,923,260 | 0.05% |
Feb 14, 2024 | Royal Bank of Canada | added | 9.85 | 79,000 | 467,000 | -% |
Feb 14, 2024 | AMERIPRISE FINANCIAL INC | sold off | -100 | -114,089 | - | -% |
Unveiling InfuSystem Holdings Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to InfuSystem Holdings Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 196.9B | 40.1B | 34.4 | 4.91 | ||||
BDX | 71.2B | 19.5B | 56.69 | 3.65 | ||||
ALGN | 24.6B | 3.9B | 55.33 | 6.38 | ||||
BAX | 21.7B | 14.8B | 8.16 | 1.46 | ||||
MID-CAP | ||||||||
BIO | 10.2B | 2.7B | -16.04 | 3.83 | ||||
HSIC | 9.7B | 12.3B | 23.21 | 0.78 | ||||
ATR | 9.5B | 3.5B | 33.57 | 2.74 | ||||
XRAY | 6.9B | 4.0B | -51.36 | 1.74 | ||||
AXNX | 3.5B | 366.4M | -577.22 | 9.59 | ||||
PDCO | 2.5B | 6.6B | 12.86 | 0.38 | ||||
SMALL-CAP | ||||||||
AHCO | 1.5B | 3.2B | -2.23 | 0.47 | ||||
ANIK | 379.3M | 166.7M | -4.59 | 2.28 | ||||
ANGO | 227.2M | 329.5M | -16.09 | 0.69 | ||||
APYX | 43.3M | 52.3M | -2.31 | 0.83 | ||||
AEMD | 4.5M | 3.7M | -0.37 | 1.19 |
InfuSystem Holdings Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Revenue | 0.5% | 31,909 | 31,735 | 30,370 | 28,830 | 27,279 | 27,042 | 26,763 | 26,519 | 26,566 | 24,834 | 24,463 | 24,711 | 25,125 | 25,999 | 21,553 | 21,710 | 21,489 | 19,723 | 18,193 | 17,563 | 16,677 |
Gross Profit | -1.2% | 16,246 | 16,442 | 15,540 | 16,084 | 16,219 | 14,901 | 15,367 | 15,313 | 15,258 | 15,050 | 14,576 | 14,996 | 15,122 | 15,978 | 12,663 | 12,947 | 12,238 | 11,356 | 10,341 | 9,973 | 9,674 |
Operating Expenses | -4.2% | 14,549 | 15,194 | 15,647 | 15,055 | 15,276 | 14,694 | 15,892 | 13,711 | 15,609 | 14,354 | 13,703 | 13,961 | 11,869 | 11,472 | 12,630 | 11,636 | 10,575 | 10,385 | 10,761 | 9,847 | 9,769 |
S&GA Expenses | -8.6% | 2,728 | 2,985 | 3,224 | 2,963 | 2,894 | 3,083 | 3,319 | 2,813 | 2,908 | 2,680 | 2,376 | 2,398 | 2,196 | 2,449 | 2,618 | 2,452 | 2,402 | 2,476 | 2,602 | 2,157 | 2,323 |
EBITDA Margin | 1.9% | 0.12* | 0.12* | 0.12* | 0.11* | 0.12* | 0.11* | 0.11* | 0.13* | 0.12* | 0.16* | 0.19* | 0.19* | - | - | - | - | - | - | - | - | - |
Interest Expenses | -9.2% | 563 | 620 | 484 | 426 | 385 | 314 | 277 | 468 | 270 | 317 | 322 | 237 | 283 | 332 | 403 | 468 | 488 | 488 | 460 | 439 | 370 |
Income Taxes | 121.0% | 431 | 195 | -302 | 443 | 104 | 27.00 | -462 | 711 | -217 | -478 | -179 | -9,881 | 38.00 | 25.00 | 29.00 | 12.00 | 29.00 | 63.00 | 59.00 | -56.00 | 45.00 |
Earnings Before Taxes | 77.8% | 1,120 | 630 | -626 | 550 | 547 | -137 | -830 | 1,098 | -665 | 342 | 482 | 789 | 2,978 | 4,165 | -389 | 817 | 1,164 | 444 | -901 | -331 | -474 |
EBT Margin | 46.3% | 0.01* | 0.01* | 0.00* | 0.00* | 0.01* | 0.00* | 0.00* | 0.01* | 0.01* | 0.05* | 0.08* | 0.08* | - | - | - | - | - | - | - | - | - |
Net Income | 58.4% | 689 | 435 | -324 | 107 | 443 | -164 | -368 | 387 | -448 | 820 | 661 | 10,670 | 2,940 | 4,140 | -418 | 805 | 1,135 | 381 | -960 | -275 | -519 |
Net Income Margin | 32.0% | 0.01* | 0.01* | 0.00* | 0.00* | 0.00* | -0.01* | 0.00* | 0.01* | 0.12* | 0.15* | 0.18* | 0.18* | - | - | - | - | - | - | - | - | - |
Free Cashflow | 82.1% | 4,142 | 2,275 | -468 | 4,155 | 3,221 | 5,259 | 3,900 | 3,338 | 5,518 | 5,967 | 2,513 | 7,383 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Assets | -0.7% | 102 | 103 | 102 | 99.00 | 99.00 | 99.00 | 98.00 | 98.00 | 95.00 | 96.00 | 91.00 | 97.00 | 80.00 | 84.00 | 83.00 | 79.00 | 78.00 | 72.00 | 67.00 | 64.00 | 64.00 |
Current Assets | 3.8% | 30.00 | 29.00 | 28.00 | 25.00 | 24.00 | 23.00 | 23.00 | 22.00 | 22.00 | 22.00 | 23.00 | 30.00 | 21.00 | 23.00 | 21.00 | 19.00 | 19.00 | 17.00 | 16.00 | 18.00 | 17.00 |
Cash Equivalents | 20.1% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.00 | 10.00 | 2.00 | 0.00 | 0.00 | 3.00 | 3.00 | 2.00 | 2.00 | 4.00 | 4.00 |
Inventory | 6.7% | 6.00 | 6.00 | 6.00 | 5.00 | 5.00 | 5.00 | 4.00 | 4.00 | 4.00 | 4.00 | 3.00 | 3.00 | 4.00 | 4.00 | 4.00 | 3.00 | 3.00 | 3.00 | 3.00 | 2.00 | 2.00 |
Net PPE | -1.6% | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 5.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 3.00 | 2.00 | 1.00 | 1.00 | 1.00 |
Goodwill | 0% | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | - | - | - | - | - | - | - | - | - | - | - |
Liabilities | -4.2% | 51.00 | 53.00 | 54.00 | 51.00 | 51.00 | 52.00 | 52.00 | 49.00 | 48.00 | 51.00 | 48.00 | 56.00 | 51.00 | 58.00 | 61.00 | 57.00 | 56.00 | 52.00 | 48.00 | 44.00 | - |
Current Liabilities | 10.9% | 14.00 | 13.00 | 14.00 | 14.00 | 13.00 | 14.00 | 14.00 | 13.00 | 14.00 | 16.00 | 12.00 | 23.00 | 20.00 | 20.00 | 24.00 | 22.00 | 22.00 | 21.00 | 18.00 | 15.00 | 15.00 |
Long Term Debt | -9.6% | 33.00 | 36.00 | 36.00 | 33.00 | 34.00 | 34.00 | 35.00 | 33.00 | 31.00 | 32.00 | 32.00 | 29.00 | 27.00 | 33.00 | 32.00 | 30.00 | 30.00 | 27.00 | 28.00 | 29.00 | 29.00 |
LT Debt, Current | - | - | - | - | - | - | - | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | 9.00 | 8.00 | 8.00 | 7.00 | 8.00 | 7.00 | 6.00 | 5.00 | 5.00 | 5.00 |
LT Debt, Non Current | -9.6% | 33.00 | 36.00 | 36.00 | 33.00 | 34.00 | 34.00 | 35.00 | 33.00 | 31.00 | 32.00 | 32.00 | 29.00 | 27.00 | 33.00 | 32.00 | 30.00 | 30.00 | 27.00 | 28.00 | 29.00 | 29.00 |
Shareholder's Equity | 3.0% | 51.00 | 50.00 | 48.00 | 48.00 | 48.00 | 46.00 | 46.00 | 48.00 | 46.00 | 45.00 | 43.00 | 41.00 | 29.00 | 26.00 | 22.00 | 22.00 | 22.00 | 20.00 | 20.00 | 20.00 | 21.00 |
Retained Earnings | 1.2% | -58.70 | -59.39 | -59.82 | -59.34 | -59.35 | -58.79 | -58.28 | -53.90 | -43.00 | -42.55 | -43.37 | -44.03 | -54.70 | -57.64 | -61.78 | -61.37 | -62.17 | -63.31 | -63.69 | -62.73 | -62.45 |
Additional Paid-In Capital | 0.6% | 109 | 108 | 107 | 106 | 106 | 104 | 103 | 102 | 89.00 | 87.00 | 86.00 | 85.00 | 84.00 | 84.00 | 84.00 | 84.00 | 84.00 | 84.00 | 83.00 | 83.00 | 83.00 |
Shares Outstanding | 0.6% | 21.00 | 21.00 | 21.00 | 21.00 | 21.00 | 21.00 | 21.00 | 21.00 | 20.00 | 20.00 | 20.00 | 20.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | - | - | 172 | - | - | - | 370 | - | - | - | 151 | - | - | - | 52.00 | - | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Cashflow From Operations | 73.9% | 4,264 | 2,452 | -151 | 4,566 | 3,456 | 5,417 | 4,078 | 3,711 | 5,791 | 6,163 | 2,651 | 7,612 | 8,406 | 3,705 | 557 | 4,341 | 5,215 | 3,050 | 1,269 | 3,181 | 3,364 |
Share Based Compensation | 4.6% | 1,063 | 1,016 | 720 | 589 | 1,066 | 1,123 | 1,047 | 1,442 | 1,955 | 1,372 | 1,635 | 1,388 | 659 | 357 | 206 | 217 | 250 | - | - | - | - |
Cashflow From Investing | 87.2% | -300 | -2,339 | -3,051 | -3,052 | -3,502 | -2,781 | -2,143 | -5,627 | -4,424 | -8,462 | -2,802 | -3,212 | -458 | -4,456 | -4,036 | -5,462 | -7,621 | -3,789 | -2,771 | -2,807 | -1,154 |
Cashflow From Financing | -1575.3% | -3,937 | -235 | 3,293 | -1,712 | 98.00 | -2,730 | -1,716 | 1,937 | -1,366 | -298 | -6,736 | 3,309 | -6,491 | 928 | 1,137 | 611 | 3,861 | 541 | -916 | 62.00 | -689 |
Buy Backs | - | - | - | 153 | 100 | 1,003 | 350 | 4,006 | 560 | - | - | - | - | - | - | - | - | - | - | - | 104 | 9,027 |
Condensed Consolidated Statements of Operations and Comprehensive Income - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Income Statement [Abstract] | ||||
Net revenues | $ 31,909 | $ 27,279 | $ 94,014 | $ 81,084 |
Cost of revenues | 15,663 | 11,060 | 45,786 | 34,597 |
Gross profit | 16,246 | 16,219 | 48,228 | 46,487 |
Selling, general and administrative expenses: | ||||
Provision for doubtful accounts | (169) | (90) | (122) | (84) |
Amortization of intangibles | 248 | 704 | 743 | 2,125 |
Selling and marketing | 2,728 | 2,894 | 8,937 | 9,296 |
General and administrative | 11,742 | 11,768 | 35,832 | 34,525 |
Total selling, general and administrative | 14,549 | 15,276 | 45,390 | 45,862 |
Operating income | 1,697 | 943 | 2,838 | 625 |
Other expense: | ||||
Interest expense | (563) | (385) | (1,667) | (976) |
Other expense | (14) | (11) | (47) | (69) |
Income (loss) before income taxes | 1,120 | 547 | 1,124 | (420) |
(Provision for) benefit from income taxes | (431) | (104) | (324) | 331 |
Net income (loss) | $ 689 | $ 443 | $ 800 | $ (89) |
Net income (loss) per share: | ||||
Basic (in dollars per share) | $ 0.03 | $ 0.02 | $ 0.04 | $ 0 |
Diluted (in dollars per share) | $ 0.03 | $ 0.02 | $ 0.04 | $ 0 |
Weighted average shares outstanding: | ||||
Basic (in shares) | 21,095,404 | 20,683,366 | 20,968,711 | 20,625,826 |
Diluted (in shares) | 21,719,404 | 21,452,483 | 21,615,706 | 20,625,826 |
Comprehensive income: | ||||
Net income (loss) | $ 689 | $ 443 | $ 800 | $ (89) |
Other comprehensive income: | ||||
Unrealized gain on hedges | 254 | 605 | 200 | 1,754 |
Provision for income tax on unrealized hedge gain | (62) | (146) | (55) | (423) |
Net comprehensive income | $ 881 | $ 902 | $ 945 | $ 1,242 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 161 | $ 165 |
Accounts receivable, net | 19,455 | 16,871 |
Inventories | 6,091 | 4,821 |
Other current assets | 4,012 | 2,922 |
Total current assets | 29,719 | 24,779 |
Medical equipment for sale or rental | 3,975 | 2,790 |
Medical equipment in rental service, net of accumulated depreciation | 35,278 | 39,450 |
Property & equipment, net of accumulated depreciation | 4,233 | 4,385 |
Goodwill | 3,710 | 3,710 |
Intangible assets, net | 7,694 | 8,436 |
Operating lease right of use assets | 4,291 | 4,168 |
Deferred income taxes | 9,245 | 9,625 |
Derivative financial instruments | 2,165 | 1,965 |
Other assets | 1,761 | 80 |
Total assets | 102,071 | 99,388 |
Current liabilities: | ||
Accounts payable | 7,629 | 8,341 |
Current portion of long-term debt | 0 | 0 |
Other current liabilities | 6,646 | 6,126 |
Total current liabilities | 14,275 | 14,467 |
Long-term debt, net of current portion | 32,655 | 33,157 |
Operating lease liabilities, net of current portion | 3,672 | 3,761 |
Total liabilities | 50,602 | 51,385 |
Stockholders’ equity: | ||
Preferred stock, $0.0001 par value: authorized 1,000,000 shares; none issued | 0 | 0 |
Common stock, $0.0001 par value: authorized 200,000,000 shares; 21,183,526 shares issued and outstanding as of September 30, 2023 and 20,781,977 shares issued and outstanding as of December 31, 2022 | 2 | 2 |
Additional paid-in capital | 108,530 | 105,856 |
Accumulated other comprehensive income | 1,634 | 1,489 |
Retained deficit | (58,697) | (59,344) |
Total stockholders’ equity | 51,469 | 48,003 |
Total liabilities and stockholders’ equity | $ 102,071 | $ 99,388 |